Published in Lancet on August 25, 1984
Lay epidemiology and the rationality of responses to health education. Br J Gen Pract (1991) 2.88
Dietary salt and hypertension: treatment and prevention. Br Med J (Clin Res Ed) (1985) 1.02
End of static decade for coronary disease? Br Med J (Clin Res Ed) (1984) 0.75
Dietary salt intake and epidemiological studies. Gut (1988) 0.75
End of static decade for coronary heart disease? Br Med J (Clin Res Ed) (1984) 0.75
Food propagandists--the new puritans. J R Coll Gen Pract (1985) 0.75
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation (2006) 10.05
Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med (1991) 6.08
Essential hypertension: renin and aldosterone, heart attack and stroke. N Engl J Med (1972) 4.80
Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol (1992) 4.65
How common is white coat hypertension? JAMA (1988) 4.42
Low urinary sodium is associated with greater risk of myocardial infarction among treated hypertensive men. Hypertension (1995) 4.35
Relation between coronary risk and coronary mortality in women of the Renfrew and Paisley survey: comparison with men. Lancet (1992) 4.18
Captopril in the treatment of clinical hypertension and cardiac failure. Lancet (1979) 3.93
Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med (1991) 3.86
Plasma cholesterol, coronary heart disease, and cancer in the Renfrew and Paisley survey. BMJ (1989) 3.74
Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases. N Engl J Med (1972) 3.73
Detection of coronary stenoses on source and projection images using three-dimensional MR angiography with retrospective respiratory gating: preliminary experience. AJR Am J Roentgenol (1998) 3.58
Reduced thirst after water deprivation in healthy elderly men. N Engl J Med (1984) 3.13
Examination of clinical examiners. Lancet (1969) 3.07
Modern strategies to prevent coronary sequelae and stroke in hypertensive patients differ from the JNC V Consensus Guidelines. Am J Hypertens (1994) 2.91
Factors related to first dose hypotensive effect of captopril: prediction and treatment. Br Med J (Clin Res Ed) (1983) 2.90
Captopril in heart failure. A double blind controlled trial. Br Heart J (1984) 2.85
Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state. Br Heart J (1985) 2.74
Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol (1995) 2.74
Salt saga continued. BMJ (1988) 2.66
Cough and wheeze caused by inhibitors of angiotensin-converting enzyme. N Engl J Med (1986) 2.65
Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol (1984) 2.64
Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility. Lancet (1980) 2.63
Diagnosis and treatment of primary hyperaldosteronism. Ann Intern Med (1994) 2.62
Peripheral skin necrosis complicating beta-blockage. Br Med J (1979) 2.54
Renin is not synthesized by cardiac and extrarenal vascular tissues. A review of experimental evidence. Circulation (1994) 2.50
Influence of cimetidine on pharmacokinetics of propranolol. Br Med J (Clin Res Ed) (1981) 2.50
Cerebral complications in the treatment of accelerated hypertension. Q J Med (1979) 2.49
Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med (1986) 2.36
Renin relationships in congestive cardiac failure, treated and untreated. Am Heart J (1970) 2.33
Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients. Prog Cardiovasc Dis (1979) 2.29
Use of diazoxide in hypertension with renal failure. Br Med J (1971) 2.28
Hyperlipidaemia, hypertension, and coronary heart disease. Lancet (1995) 2.28
Treatment of phaeochromocytoma and of clonidine withdrawal hypertension with labetalol. Br J Clin Pharmacol (1976) 2.25
Removal of angiotensin by isolated perfused organs of the rat. Nature (1969) 2.24
Hyperuricemia in primary and renal hypertension. N Engl J Med (1966) 2.22
Upregulated TRPC1 channel in vascular injury in vivo and its role in human neointimal hyperplasia. Circ Res (2006) 2.22
Urinary tract in schoolgirls with covert bacteriuria. Arch Dis Child (1975) 2.21
Severe hypotension after first dose of enalapril in heart failure. Br Med J (Clin Res Ed) (1985) 2.14
Guidelines on guidelines. J Hypertens (1993) 2.11
Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease. Am J Med (1972) 2.10
Calcium-regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism. Ann Intern Med (1986) 2.04
Hydrallazine in hypertension: is there a safe dose? Br Med J (1980) 1.99
Vascular remodeling. Hypertension (1996) 1.99
Usefulness and limitations of saralasin, a partial competitive agonist of angioten II, for evaluating the renin and sodium factors in hypertensive patients. Am J Med (1976) 1.98
Medical ethics: some reservations. J Med Ethics (1982) 1.98
Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines. J Hypertens (2003) 1.93
Medical Investigation of Retinal Vascular Occlusion. Br Med J (1964) 1.93
Artery and vein separation using susceptibility-dependent phase in contrast-enhanced MRA. J Magn Reson Imaging (2000) 1.91
Hypertension with aldosterone excess and low plasma-renin: preoperative distinction between patients with and without adrenocortical tumour. Lancet (1970) 1.90
Radio-immunoassay for plasma alpha human atrial natriuretic peptide: a comparison of direct and pre-extracted methods. J Hypertens (1987) 1.90
The renin system: Variations in man measured by radioimmunoassay or bioassay. Kidney Int (1972) 1.87
The estimation of renin in human plasma. Biochem J (1964) 1.85
Essential hypertension: a disorder of growth with origins in childhood? J Hypertens (1992) 1.85
Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. J Clin Invest (1986) 1.84
Reversal of vascular and renal crises of scleroderma by oral angiotensin-converting-enzyme blockade. N Engl J Med (1979) 1.83
Plasma Renin Concentration in Human Hypertension-III: Renin in Relation to Complications of Hypertension. Br Med J (1966) 1.83
Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles. Am J Med (1973) 1.82
An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients. N Engl J Med (1974) 1.82
Effects of 1,25-dihydroxycholecalciferol on calcium absorption, muscle weakness, and bone disease in chronic renal failure. Lancet (1974) 1.80
Amiloride. A potassium-sparing natriuretic agent. Circulation (1968) 1.80
Angiotensin-II blockade in man by sar1-ala8-angiotensin II for understanding and treatment of high blood-pressure. Lancet (1973) 1.78
Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term. Hypertension (1990) 1.77
Effects of auriculin (atrial natriuretic factor) on blood pressure, renal function, and the renin-aldosterone system in dogs. Am J Med (1984) 1.76
Captopril in renovascular hypertension: long-term use in predicting surgical outcome. Br Med J (Clin Res Ed) (1982) 1.76
Successful use of oral diazoxide in the treatment of severe toxaemia of pregnancy. Br Med J (1972) 1.76
Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis. N Engl J Med (1985) 1.75
Direct relationship between blood pressure and blood viscosity in normal and hypertensive subjects. Role of fibrinogen and concentration. Am J Med (1981) 1.75
The amplifier hypothesis: permission to dissent? J Hypertens (1999) 1.73
Relation of left ventricular hemodynamic load and contractile performance to left ventricular mass in hypertension. Circulation (1990) 1.72
Mortality in patients of the Glasgow Blood Pressure Clinic. J Hypertens (1986) 1.71
A novel multiply primed polymerase chain reaction assay for identification of variant papG genes encoding the Gal(alpha 1-4)Gal-binding PapG adhesins of Escherichia coli. J Infect Dis (1996) 1.70
"Third drug" trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic. Br Med J (Clin Res Ed) (1984) 1.69
Captopril: five years on. Br Med J (Clin Res Ed) (1983) 1.68
Blood pressure during normal daily activities, sleep, and exercise. Comparison of values in normal and hypertensive subjects. JAMA (1982) 1.68
Combined treatment of severe intractable hypertension with captopril and diuretic. Lancet (1980) 1.68
Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension. J Am Coll Cardiol (1994) 1.67
On dinosaurs and medical textbooks. Lancet (1995) 1.67
Identification of two previously unrecognized genes (guaA and argC) important for uropathogenesis. Mol Microbiol (1996) 1.67
Telomere length in small-for-gestational-age babies. BJOG (2006) 1.66
Renin and acute renal failure: studies in man. Br Med J (1970) 1.66